HotCopper on MSN2d
Nyrada doses first cohort in trial to assess neuroprotective, cardioprotective drugDrug development company Nyrada (ASX:NYR) has dosed the first cohort of patients in a trial to assess its lead drug candidate ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback